# A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

> **NCT00540501** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Oseltamivir and Intravenous Zanamivir

## Key facts

- **NCT ID:** NCT00540501
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Contract agreement not reached
- **Last updated:** 2010-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540501, "A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00540501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*